Chemical peeling with 35% GA significantly improves disseminated facial verruca plana: a randomized split-face trials

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048532

Enrollment

Unknown

Registered

2021-07-10

Start date

2020-07-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial verruca plana

Interventions

experimental group:35% Glycolic acid

control group:Adarapalin Gel

Eligibility

Sex/Gender

All

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Clinical diagnosis for flat warts, skin lesions in the face, the performance of light red, skin color or taupe slightly higher than the flat papules, the number of >=10; 15 to 50 years old, no other treatment within 3 months; Non-scar constitution; No facial suppurative or allergic disease.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women; A history of hypertrophic scarring or keloid; People with skin sensitivity or allergy to retinoids; Complicated with systemic diseases or severe immunodeficiency; Patients treated with other methods within the last 3 months.

Design outcomes

Primary

Measure	Time frame
Number of the lesions;clearance rate;	—

Countries

China

Contacts

Public ContactLiu Zhen-Feng

Dermatology Hospital of Southern Medical University

liuzhenfengpuma@163.com+86 18011788797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026